| Friday,
September 13, 2002 |
| 8:30 |
Introduction
Patrick Marcellin, France |
| |
Session
1: Natural History and Pathogenesis |
| |
Chairpersons:
Alfredo Alberti, Italy
Nikolai Naoumov, UK |
| 8:40 |
Molecular Heterogeneity of Hepatitis
B Virus
Hans Will, Germany |
| 8:55 |
Virological
Essays
Giovanni Raimondo, Italy |
| 9:05 |
HBV
DNA Essays and Viral Kinetics
Jean-Michel Pawlotsky, France |
| 9:15 |
Immuno-pathogenesis
Carlo Ferrari, Italy |
| 9:30 |
Liver
Tissue Examination
Valer Desmet, Belgium |
| 9:45 |
Natural
History
Giovanna Fattovich, Italy |
| 10:00 |
Hepatitis
B Virus and Hepatocellular Carcinoma
Jordi Bruix, Spain |
| 10:15 |
Discussion |
| 10:45 |
Coffee Break |
|
| 11:15 - 13:00
|
Session 2: Epidemiology
and Prevention
Chairpersons:
Daniel Shouval, Israel
Pierre Van Damme, Belgium |
| 11:15 |
Epidemiology
of Hepatitis B in Europe and Worldwide
Miriam Alter, CDC, USA |
| 11:30 |
Hepatitis
B Vaccines
Daniel Shouval, Israel |
| 11:45 |
Impact
of Immunization in Europe and Worldwide
Pem Namgyal, Switzerland |
| 12:00 |
Safety
of Immunization and Adverse Events following Vaccination against
Hepatitis B
Philippe Duclos, Switzerland |
| 12:15 |
Health
Care Workers and Hepatitis B
Michael Roggendorf, Germany |
| 12:30 |
Discussion |
| 13:00 |
Lunch Break |
|
| 14:15 - 16:00 |
Session 3: Treatment of
HBeAg Positive Chronic
Hepatitis B
Chairpersons:
Geoffrey Dusheiko, UK
Stephan Zeuzem, Germany |
| 14:15 |
Mechanisms
of Action of Interferon and Nucleoside Analogues
Howard Thomas, UK |
| 14:30 |
Results
of Interferon Alpha
Antonio Craxi, Italy |
| 14:45 |
Results
of Lamivudine in Western Trials
Jenny Heathcote, Canada |
| 15:00 |
Results
of Lamivudine in Asian Trials
Yun-Fan Liaw, Taiwan |
| 15:15 |
Results
of Adefovir
Geoffrey Dusheiko, UK |
| 15:30 |
Discussion |
| 16:00 |
Coffee Break |
|
| 16:30 - 18:00 |
Session 4: Viral Resistance,
New Drugs and New Therapeutic Strategies
Chairpersons:
Stephanos Hadziyannis, Greece
Fabien Zoulim, France |
| 16:30 |
Viral
Resistance: Mechanisms and Diagnosis
Stephen Locarnini, Australia |
| 16:45 |
Viral
Resistance: Clinical Implications and Management
Fabien Zoulim, France |
| 17:00 |
Entecavir,
FTC, LFMAU, LDT and Others
Rafael Esteban, Spain |
| 17:15 |
Pegylated
Interferon
Graham Cooksley, Australia |
| 17:30 |
Combination
Therapy
Solko Schalm, The Netherlands |
| 17:45 |
Immunomodulatory
Drugs and Therapeutic Vaccines
Stanislas Pol, France |
| 18:00 |
Discussion |
| |
| Saturday,
September 14, 2002 |
| 9:00 - 10:30 |
Session 5: Treatment of
HBeAg Negative Chronic
Hepatitis B
Chairpersons:
Mario Rizzetto, Italy
Massimo Colombo, Italy |
| 9:00 |
HBeAg
Negative Chronic Hepatitis B: an Overview
Feruccio Bonino, Italy |
| 9:15 |
Treatment
with Interferon or Pegylated Interferon
Maurizia Brunetto, Italy |
| 9:30 |
Treatment
with Lamivudine
Mario Rizzetto, Italy |
| 9:45 |
Treatment
with New Drugs (Adefovir and Others)
Stephanos Hadziyannis, Greece |
| 10:00 |
Discussion |
| 10:30 |
Coffee break |
|
| 11:00 -13:15 |
Session 6: Special Populations
Chairpersons:
Didier Samuel, France
Michael Manns, Germany |
| 11:00 |
Cirrhosis
(compensated and decompensated)
Robert Perrillo, USA |
| 11:15 |
Liver
Transplantation, Indications, Prevention of Recurrence and Results
Didier Samuel, France |
| 11:30 |
Treatment
of Recurrence in Transplant Patients
Theresa Wright, USA |
| 11:45 |
Treatment
of Patients Co-infected with HIV
Yves Benhamou, France |
| 12:00 |
Treatment
of Children
Flavia Bortolotti, Italy |
| 12:15 |
Treatment
of Special Patients (Hemodialysis, Heart and Renal Transplant,
Fulminant Hepatitis, Reactivation under Immunosuppressive Therapy)
Michael Manns, Germany |
| 12:30 |
Delta
Hepatitis: an Update
Patrizia Farci, Italy |
| 12:45 |
Discussion |
| 13:15 |
Lunch Break |
|
| 14:30 - 16:00 |
Session 7: Perspectives
Chairpersons:
Patrizia Pontisso, Italy
Patrick Marcellin, France |
| 14:30 |
Perspectives
(Basic)
Christian Trépo, France |
| 14:50 |
Perspectives
of Public Health: Present and Forseen Impact of Vaccination
on the Epidemiology of Hepatitis B
Paolo Bonanni, Italy |
| 15:10 |
Perspectives
(Clinical)
Jay Hoofnagle, USA |
| 15:30 |
Discussion |
| 16:00 |
Coffee Break |
|
| 16:30-18:00 |
Final Discussion
Chairpersons:
Alfredo Alberti, Italy
Patrick Marcellin, France |
